Ross Greenberg

Evaluation of Early vs Standard Liver Transplant for Alcohol-Associated Liver Disease.

D. Segev, R. Anders, A. Gurakar, 2021, JAMA surgery.

Safety of the First Dose of SARS-CoV-2 Vaccination in Solid Organ Transplant Recipients.

D. Segev, A. Massie, R. Avery, 2021, Transplantation.

Safety and Reactogenicity of 2 Doses of SARS-CoV-2 Vaccination in Solid Organ Transplant Recipients

D. Segev, A. Massie, R. Avery, 2021, Transplantation.

SARS-CoV-2 messenger RNA vaccine antibody response and reactogenicity in heart and lung transplant recipients

R. Higgins, P. Shah, D. Segev, 2021, The Journal of Heart and Lung Transplantation.

SARS-CoV-2 Messenger RNA Vaccine Immunogenicity in Solid Organ Transplant Recipients With Prior COVID-19

D. Segev, A. Massie, R. Avery, 2021, Transplantation.

Safety and antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in patients with multiple myeloma

D. Segev, B. Boyarsky, W. Werbel, 2021, BMC Cancer.

Patient reflections, challenges, and supports related to early liver transplant for severe alcohol-associated liver disease

G. Chander, A. Cameron, Po-Hung Chen, 2023, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Evaluation of the Modified Oxford Score in Recurrent IgA Nephropathy in North American Kidney Transplant Recipients: The Banff Recurrent Glomerulonephritis Working Group Report

U. Maggiore, M. Delsante, C. Blosser, 2023, Transplantation.